G Square’s strong healthcare investment and successful investment track record in European healthcare experience provides powerful benefits. Deep industry knowledge and international network generates high-quality deal flow.
How G Square creates value
Providing expert advice and support to mid-market healthcare investments
G Square invests in mid-market entrepreneurial healthcare companies seeking funds to boost their development through organic growth, international expansion, or the acquisition of products or other companies.
The healthcare investment criteria of G Square focus on young, fast-growing companies and entrepreneurial managers, using its healthcare private equity experience to add value, both for stakeholders and shareholders. In supporting these mid-market healthcare companies, G Square accelerates their development and contributes to the strategic and operational discussions of the management.
Growth capital and buy-outs in healthcare private equity
With a successful track-record of healthcare private equity investments, G Square accelerates greenfield and external development through screening, monitoring and integration methodologies, helping companies to secure and negotiate proper financing from debt providers.
G Square works on the principle of buy-and-build medical investment strategies. Working with fairly mature businesses with high growth potential, the team of specialist healthcare investors doesn’t just place capital into these companies, but also helps them to expand effectively in a complicated and ever-changing environment.
G Square invests in companies with enterprise value up to €200 million. G Square can also underwrite and syndicate larger transactions by inviting its limited partners to co-invest.
By working with management teams, G Square invests alongside founders, owners and managers. The team develops a partnership based on the shared objective to create sustainable, economic value.
Through robust and steady monitoring and clearly identified KPIs, G Square builds the backbone for successful development in a buy-and-build platform.